These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 10502465
1. Comparison of pathogenic factors expressed by group A Streptococci isolated from patients with streptococcal toxic shock syndrome and scarlet fever. Shiseki M, Miwa K, Nemoto Y, Kato H, Suzuki J, Sekiya K, Murai T, Kikuchi T, Yamashita N, Totsuka K, Ooe K, Shimizu Y, Uchiyama T. Microb Pathog; 1999 Oct; 27(4):243-52. PubMed ID: 10502465 [Abstract] [Full Text] [Related]
2. Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections. Müller-Alouf H, Geoffroy C, Geslin P, Bouvet A, Felten A, Günther E, Ozegowski JH, Alouf JE. Zentralbl Bakteriol; 1997 Oct; 286(3):421-33. PubMed ID: 9361388 [Abstract] [Full Text] [Related]
4. [Properties of extracellular products produced by group A streptococci isolated from patients with streptococcal toxic shock syndrome]. Suzuki J, Matsubuchi S, Yoshihara E, Kobayashi S, Okamura K, Okuda T, Okazaki M, Furuya N, Uchimura H, Tokunaga T, Shimazaki S. Kansenshogaku Zasshi; 1997 Dec; 71(12):1187-92. PubMed ID: 9483877 [Abstract] [Full Text] [Related]
7. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. Eriksson BK, Andersson J, Holm SE, Norgren M. J Infect Dis; 1999 Aug; 180(2):410-8. PubMed ID: 10395857 [Abstract] [Full Text] [Related]
8. [Toxic shock-like syndrome caused by streptococci]. van Dissel JT, Kullberg BJ, van der Meer JW. Ned Tijdschr Geneeskd; 1999 Jul 10; 143(28):1452-5. PubMed ID: 10443259 [Abstract] [Full Text] [Related]
9. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E. N Engl J Med; 1989 Jul 06; 321(1):1-7. PubMed ID: 2659990 [Abstract] [Full Text] [Related]
11. Positive correlation between low adhesion of group A Streptococcus to mammalian cells and virulence in a mouse model. Miyoshi-Akiyama T, Zhao J, Uchiyama T, Yagi J, Kirikae T. FEMS Microbiol Lett; 2009 Apr 06; 293(1):107-14. PubMed ID: 19220473 [Abstract] [Full Text] [Related]
12. Erythrogenic toxin type A (ETA): epidemiological analysis of gene distribution and protein formation in clinical Streptococcus pyogenes strains causing scarlet fever and the streptococcal toxic shock-like syndrome (TSLS). Reichardt W, Müller-Alouf H, Köhler W. Zentralbl Bakteriol; 1993 Jun 06; 279(2):283-93. PubMed ID: 8219499 [Abstract] [Full Text] [Related]
13. [Streptococcus pyogenes--much more than the aetiological agent of scarlet fever]. Stock I. Med Monatsschr Pharm; 2009 Nov 06; 32(11):408-16; quiz 417-8. PubMed ID: 19947304 [Abstract] [Full Text] [Related]
18. Role of a type IV-like secretion system of Streptococcus suis 2 in the development of streptococcal toxic shock syndrome. Zhao Y, Liu G, Li S, Wang M, Song J, Wang J, Tang J, Li M, Hu F. J Infect Dis; 2011 Jul 15; 204(2):274-81. PubMed ID: 21673039 [Abstract] [Full Text] [Related]
20. The production of pyrogenic exotoxins by group A streptococci. Hallas G. J Hyg (Lond); 1985 Aug 15; 95(1):47-57. PubMed ID: 3926872 [Abstract] [Full Text] [Related] Page: [Next] [New Search]